Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Thibault

Showing results (91-100 of 124) with videos related to

Pageof 13
Sort By:
The American Journal of Gastroenterology|September 1, 2005
Longitudinal assessment of histology surrogate markers (FibroTest-ActiTest) during lamivudine therapy in patients with chronic hepatitis B infectionThierry Poynard, Fabien Zoulim, Vlad Ratziu, et al.
BMC Medical Education|October 24, 2025
ViroGame: a serious game for medical virology education - a feedback reportVincent Portet Sulla, Stephane Marot, Marion Dutkiewicz, et al.
Journal of Hepatology|May 29, 2013
Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis CThierry Poynard, Joseph Moussalli, Mona Munteanu, et al.
Journal of Hepatology|August 20, 2014
PegIFNα/ribavirin/protease inhibitor combination in severe hepatitis C virus-associated mixed cryoglobulinemia vasculitisDavid Saadoun, Matthieu Resche Rigon, Stanislas Pol, et al.
Plos One|July 4, 2008
An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (FibroTest-ActiTest) and viral loadYen Ngo, Yves Benhamou, Vincent Thibault, et al.
Alimentary Pharmacology & Therapeutics|October 19, 2018
Long-term prognostic value of the FibroTest in patients with non-alcoholic fatty liver disease, compared to chronic hepatitis C, B, and alcoholic liver diseaseMona Munteanu, Raluca Pais, Valentina Peta, et al.
Annals of the Rheumatic Diseases|November 15, 2015
Sofosbuvir plus ribavirin for hepatitis C virus-associated cryoglobulinaemia vasculitis: VASCUVALDIC studyDavid Saadoun, Vincent Thibault, Si Nafa Si Ahmed, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 7, 2021
Chilblains during lockdown are associated with household exposure to SARS-CoV-2: a multicentre case-control studyFlorence Poizeau, Emmanuel Oger, Sébastien Barbarot, et al.
Journal of Clinical Microbiology|February 4, 2006
Unique NS5b hepatitis C virus gene sequence consensus database is essential for standardization of genotype determinations in multicenter epidemiological studiesSyria Laperche, Karine Saune, Paul Dény, et al.
Journal of Hepatology|December 3, 2013
Staging chronic hepatitis C in seven categories using fibrosis biomarker (FibroTest™) and transient elastography (FibroScan®)Thierry Poynard, Julien Vergniol, Yen Ngo, et al.
Pageof 13

Showing results (91-100 of 124) with videos related to

Sort By:
Pageof 13
The American Journal of Gastroenterology|September 1, 2005
Longitudinal assessment of histology surrogate markers (FibroTest-ActiTest) during lamivudine therapy in patients with chronic hepatitis B infectionThierry Poynard, Fabien Zoulim, Vlad Ratziu, et al.
BMC Medical Education|October 24, 2025
ViroGame: a serious game for medical virology education - a feedback reportVincent Portet Sulla, Stephane Marot, Marion Dutkiewicz, et al.
Journal of Hepatology|May 29, 2013
Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis CThierry Poynard, Joseph Moussalli, Mona Munteanu, et al.
Journal of Hepatology|August 20, 2014
PegIFNα/ribavirin/protease inhibitor combination in severe hepatitis C virus-associated mixed cryoglobulinemia vasculitisDavid Saadoun, Matthieu Resche Rigon, Stanislas Pol, et al.
Plos One|July 4, 2008
An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (FibroTest-ActiTest) and viral loadYen Ngo, Yves Benhamou, Vincent Thibault, et al.
Alimentary Pharmacology & Therapeutics|October 19, 2018
Long-term prognostic value of the FibroTest in patients with non-alcoholic fatty liver disease, compared to chronic hepatitis C, B, and alcoholic liver diseaseMona Munteanu, Raluca Pais, Valentina Peta, et al.
Annals of the Rheumatic Diseases|November 15, 2015
Sofosbuvir plus ribavirin for hepatitis C virus-associated cryoglobulinaemia vasculitis: VASCUVALDIC studyDavid Saadoun, Vincent Thibault, Si Nafa Si Ahmed, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 7, 2021
Chilblains during lockdown are associated with household exposure to SARS-CoV-2: a multicentre case-control studyFlorence Poizeau, Emmanuel Oger, Sébastien Barbarot, et al.
Journal of Clinical Microbiology|February 4, 2006
Unique NS5b hepatitis C virus gene sequence consensus database is essential for standardization of genotype determinations in multicenter epidemiological studiesSyria Laperche, Karine Saune, Paul Dény, et al.
Journal of Hepatology|December 3, 2013
Staging chronic hepatitis C in seven categories using fibrosis biomarker (FibroTest™) and transient elastography (FibroScan®)Thierry Poynard, Julien Vergniol, Yen Ngo, et al.
Pageof 13